MMJ Group Holdings Limited (ASX: MMJ) ("MMJ") is pleased to attach a copy of a news release announcing that MediPharm Labs Inc (“MediPharm Labs”) (TSX-V: LABS) has expanded its annual production capacity by 50 per cent.
MMJ owns approximately 4.4 million shares for a 4.5% shareholding and 2.9 million warrants (exercisable at CAD$1.20 per share by October 2020) in MediPharm Labs.
For more information, download the attached PDF.
Download this document
